MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 04:04:59 2024-06-26 pm EDT | ||
| 6.21 EUR | 0.00% |
|
| Current month | +13.81% | ||
| 1 month | +19.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 6.18 | +3.00% |
| 24-06-25 | 6 | -8.54% |
| 24-06-24 | 6.56 | +13.30% |
| 24-06-21 | 5.79 | 0.00% |
| 24-06-20 | 5.79 | +33.41% |
Real-time Borsa Italiana
Last update June 26, 2024 at 04:04 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1XU17 | |
| ISIN | NLBNPIT1XU17 |
| Date issued | 2023-12-18 |
| Strike | 43.69 € |
| Maturity | 2035-12-20 (4194 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.25 € |
|---|---|
| Lowest since issue | 3.81 € |
| Spread | 0.59 € |
| Spread % | 9.10% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.62
EUR
Average target price
52.64
EUR
Spread / Average Target
+6.09%
- Stock Market
- Certificates
- P1XU17 Certificat
